Ana Laura Di Virgilio

Dr. Ana Laura Di Virgilio


Biography

Since 2010, I have been working on a project investigating the antitumor effects of various metal complexes in cultured cells through direct exposure and controlled drug release systems. Metallodrugs are used in the treatment of various diseases such as cancer. In collaboration with different groups, we obtained and characterized complexes of vanadium, copper, ruthenium, and platinum with ligands that present various functional groups suitable for metal coordination (flavonoids, saccharinate, glutamate, quinolines, clioquinol, sulfamethazine, sulfaquinoxaline, etc.). The effect of metallodrugs and their precursors on cell viability, as well as cyto- and genotoxicity and intracellular mechanisms of action (oxidative stress, mitochondrial membrane potential, apoptosis, cell cycle arrest, etc.) were also investigated. On the other hand, since 2016, I have been working on a project that aims to offer new options for drug delivery. Nanoscience and nanotechnology are used in early diagnosis and effective cancer treatment. Our work group has acquired solid experience in the synthesis and characterization of core@shell and @shell nanostructured materials. Furthermore, we have experience studying the cytotoxicity and genotoxicity of metallic nanoparticles in different cell lines, as well as mesoporous silica particles synthesized with shells of different metal oxides.

Affiliations

No affiliation has been shared yet.

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.